Target intelligence / Profile preview

Reduction of inflammatory cytokine production via immune modulation by lactic acid bacteria

Molecular classification
Other (not a single molecule or receptor; refers to a biological process involving multiple pathways and cell types)
01

Overview

The entry "Inflammatory cytokine production reduction via immune modulation by lactic acid bacteria strains" does not refer to a specific molecular target such as a receptor, enzyme, or transporter. Instead, it describes a broad biological process whereby certain strains of lactic acid bacteria (LAB)—including species like Lactobacillus and Bifidobacterium—modulate the host's immune system. This immunomodulation can lead to reduced production of pro-inflammatory cytokines and increased levels of regulatory or anti-inflammatory mediators. LAB interact with the gut mucosa and local immune cells such as dendritic cells and macrophages. These interactions can result in changes in both innate and adaptive immunity—such as enhanced phagocytic activity, increased secretion of IgA antibodies, balanced T-helper cell responses, upregulation or downregulation of various interleukins (ILs), tumor necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma), among others[1][2][3]. The effects are strain-dependent and may involve bacterial metabolites like exopolysaccharides. This is not considered a canonical therapeutic target but rather an area describing the mechanism-of-action for probiotic interventions aimed at modulating inflammation-related diseases including infections, allergies, gastrointestinal disorders, and some cancers[8]. Because this entry is not a single molecule/receptor but rather an umbrella term for complex host-microbe interactions affecting inflammatory signaling pathways through multiple mechanisms—and because it lacks specificity—it should be flagged as incorrect if used where only molecular targets are appropriate. "Many studies have demonstrated that LAB induce functional modifications in immune cells... focusing on increased cytokine production... However... these effects extend beyond innate immunity..."[2] "In analyses... the most remarkable effect was the increase in tumor necrosis factor alpha (TNF-alpha) and gamma interferon (IFN-gamma) ...and regulatory cytokine IL‑10 for all probiotic strains assayed. This effect was obtained without increasing the inflammatory response..."[3]

Other names
Immune modulation by lactic acid bacteriaLAB-mediated cytokine regulationProbiotic immunomodulation
02

Mechanism of action

Modulation of innate and adaptive immune responses through interaction with antigen-presenting cells (e.g., dendritic cells, macrophages), leading to altered cytokine profiles[1][2][3]

03

Biological functions

Immune responseInflammatory response regulationCytokine production modulation
04

Disease associations

InflammationInfectionAllergic disease
05

Safety considerations

Generally considered safe as probiotics; rare cases of infection in immunocompromised individuals have been reported[8]
06

Biomarkers

Levels of pro-inflammatory cytokines (e.g., TNF-alpha, IL-6)Levels of anti-inflammatory cytokines (e.g., IL-10)[1][3]

Beyond the preview

Go deeper on Reduction of inflammatory cytokine production via immune modulation by lactic acid bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reduction of inflammatory cytokine production via immune modulation by lactic acid bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call